PRELIMINARY STUDIES ON THE EFFECT OF UKRAIN (TRIS{2-{[5BS-(5BA,6B,12BA)]-5B,6,7,12B,13,14-HEXAHYDRO-13-METHYL[1,3] BENZODIOXOLO[5,6-C]-1-3-DIOXOLO[4,5-i]PHENANTHRIDINIUM-6-OL]-ETHANEAMINYL}PHOSPHINESULFIDE.6HCL) ON THE IMMUNOLOGICAL RESPONSE IN PATIENTS WITH MALIGNANT TUMOURS

DANILOS J.,¹* ZBROJA-SONTAG W.,¹ BARAN E.,¹ KURYLCIO L.,² KONDRATOWICZ L.,² JUSIAK L.³

1) Hospital for Obstetrics and Gynaecology, Lubartowska 81, Lublin, Poland.
2) Oncology Hospital, Jacrewskiego 8, Lublin, Poland.
3) Department of Inorganic and Analytical Chemistry, Medical Academy, Stasrica 4, Lublin, Poland.

*Author to whom correspondence should be addressed.

Summary: Preliminary clinical observations and studies on immunological response-indicators were made in eight patients with malignant tumours, who had been administered parenteral injections of Ukrain. The results suggest that the preparation is a non-toxic immunostimulator inducing production of thymodependent T lymphocytes. The preparation improves general health of patients, has anti-allergic action, and sedative and anti-inflammatory effects. It can inhibit growth of malignant tumours.